UMCG spinout CC Diagnostics has been backed by Carduso Capital as it moves closer to the launch of its cervical cancer screening technology.

The Groningen spinout is developing antibiotics that could help overcome increasing bacterial resistance to existing drugs.

The genetic data services provider raised the cash from GSK as part of a collaboration deal, taking its total funding past $790m.

The nanopore sequencing platform developer has closed a $15.5m series 3 round backed by Baidu Ventures.

RXQ has been backed by Ohio Innovation Fund as it prepares to build beyond its current location at the Ohio University Innovation Center.

UNC Chapel Hill plans to build a life science incubator by 2019 in a bid to convince more faculty spinouts to remain based at the university.

Azafaros has licensed intellectual property from Leiden University and Amsterdam UMC's Academic Medical Centre to target lysosomal storage disorders.

UMC Utrecht spinout Gadeta has partnered cancer drug developer Kite to drive development of its T-cell therapy, allowing Kite to purchase equity from Gadeta's existing shareholders.